SEC FORM 4
$461,070.38
UNITED THERAPEUTICS Corp (UTHR)
Sale of 940 shares at $490.5004 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Sep 3, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001106578-26-000135 · filed 2026-09-04 · View filing →